Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in
the development and sale of broadly enabling, pressure-based instruments,
consumables, and platform technology solutions to the worldwide biotechnology,
biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage
industries, today announced its plan to change the company’s name to Availa Bio
upon completion of the acquisitions and merger of Cannaworx, Inc. and
SkinScience Labs, Inc. The three companies will function as synergistic
divisions within the combined “Availa Bio” entity, which will focus on
optimizing bioavailability, absorption, quality and performance of human,
animal and agricultural products. “PBI’s UST platform offers the potential to
deliver an extraordinary breakthrough in creating unique, high quality nanoemulsions
of oil in water. A vast range of personal care and consumption products,
including nutraceuticals, cosmetics, pharmaceuticals, food & beverages, all
face the perplexing challenge of getting active oil-based nutrients or
therapeutic ingredients to become easily absorbable and effective in the
water-based biology of our bodies. The opportunity to combine our strong
engineering and biotech capabilities with two companies that already provide
product innovation and brand leadership in diverse consumer product areas is
very exciting and allows us to clearly move the identity and market focus of
the combined companies from science platforms to the value delivery of
availability and performance of active ingredients in final products,” Pressure
BioScience president and CEO Richard T. Schumacher stated in the news release.
In addition, the company was recently highlighted in a Small
Caps Daily article discussing the recently announced acquisitions (http://ibn.fm/zoMja). Among
other highlights, the article discusses how the company will advance following
the acquisitions of Cannaworx, a company with a strong and diversified
portfolio of U.S. hemp-derived CBD products and intellectual property, and the
SkinScience(R) brand, a profitable and highly renowned company within the cosmetics
space. Both the letter of intent (“LOI”) between Cannaworx, Inc. and
SkinScience Labs, and the letter of intent between PBIO and Cannaworx, Inc. are
subject to certain closing conditions, including satisfaction of all due
diligence and acquisition financing.
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale
of innovative, broadly enabling, pressure-based solutions for the worldwide
life-sciences industry. The company’s products are based on the unique
properties of both constant (i.e., static) and alternating (i.e.,
pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented,
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction).
PBIO’s primary focus is in the development of PCT-based products for biomarker
and target discovery, drug design and development, biotherapeutics
characterization and quality control, soil and plant biology, forensics and counter-bioterror
applications. Additionally, major new market opportunities have emerged in the
use of its pressure-based technologies in the following areas: (1) the use of
its recently acquired, patented technology from BaroFold Inc. (the “BaroFold”
technology) to allow entry into the biopharma contract services sector, and (2)
the use of its recently patented, scalable, high-efficiency, pressure-based
Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of
otherwise immiscible fluids (e.g., oils and water) and (ii) prepare
higher-quality, homogenized, extended shelf-life or room-temperature, stable,
low-acid liquid foods that cannot be effectively preserved using existing
nonthermal technologies. For more information, visit the company’s website
at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates
relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
